Oscar Health, Inc. (NYSE: OSCR) Stock Competitors & Peer Comparison
See OSCR's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for OSCR and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OSCR | $28.87 | -5.44% | 7.5B | 20.61 | $1.40 | N/A |
| UNH | $375.01 | +1.00% | 340.6B | 20.12 | $18.64 | +2.42% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| CVS | $85.05 | -0.94% | 108.5B | 10.85 | $7.84 | +3.14% |
| ELV | $398.25 | -0.08% | 86.4B | 13.55 | $29.39 | +1.72% |
| CI | $265.50 | -1.03% | 70.1B | 8.59 | $30.90 | +2.33% |
| HUM | $380.32 | +1.48% | 45.6B | 23.96 | $15.86 | +0.93% |
| CNC | $61.92 | -0.26% | 30.6B | 24.57 | $2.52 | N/A |
| MOH | $193.31 | +2.08% | 10.1B | 27.95 | $6.92 | N/A |
| CLOV | $4.51 | -1.31% | 2.3B | 105.77 | $0.04 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
OSCR vs UNH Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, UNH has a market cap of 340.6B. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while UNH trades at $375.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas UNH's P/E ratio is 20.12. In terms of profitability, OSCR's ROE is +0.39%, compared to UNH's ROE of +0.15%. Regarding short-term risk, OSCR is more volatile compared to UNH. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check UNH's competition here
Elevance Health Inc. (NYSE: ANTM)
OSCR vs ANTM Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas ANTM's P/E ratio is 18.99. In terms of profitability, OSCR's ROE is +0.39%, compared to ANTM's ROE of +0.11%. Regarding short-term risk, OSCR is more volatile compared to ANTM. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check ANTM's competition here
CVS Health Corp. (NYSE: CVS)
OSCR vs CVS Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, CVS has a market cap of 108.5B. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while CVS trades at $85.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas CVS's P/E ratio is 10.85. In terms of profitability, OSCR's ROE is +0.39%, compared to CVS's ROE of +0.06%. Regarding short-term risk, OSCR is more volatile compared to CVS. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check CVS's competition here
Elevance Health Inc. (NYSE: ELV)
OSCR vs ELV Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, ELV has a market cap of 86.4B. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while ELV trades at $398.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas ELV's P/E ratio is 13.55. In terms of profitability, OSCR's ROE is +0.39%, compared to ELV's ROE of +0.11%. Regarding short-term risk, OSCR is more volatile compared to ELV. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check ELV's competition here
Cigna Corporation (NYSE: CI)
OSCR vs CI Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, CI has a market cap of 70.1B. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while CI trades at $265.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas CI's P/E ratio is 8.59. In terms of profitability, OSCR's ROE is +0.39%, compared to CI's ROE of +0.15%. Regarding short-term risk, OSCR is more volatile compared to CI. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check CI's competition here
Humana Inc. (NYSE: HUM)
OSCR vs HUM Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, HUM has a market cap of 45.6B. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while HUM trades at $380.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas HUM's P/E ratio is 23.96. In terms of profitability, OSCR's ROE is +0.39%, compared to HUM's ROE of +0.07%. Regarding short-term risk, OSCR is more volatile compared to HUM. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check HUM's competition here
Centene Corp. (NYSE: CNC)
OSCR vs CNC Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, CNC has a market cap of 30.6B. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while CNC trades at $61.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas CNC's P/E ratio is 24.57. In terms of profitability, OSCR's ROE is +0.39%, compared to CNC's ROE of -0.24%. Regarding short-term risk, OSCR is more volatile compared to CNC. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
OSCR vs MOH Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, MOH has a market cap of 10.1B. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while MOH trades at $193.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas MOH's P/E ratio is 27.95. In terms of profitability, OSCR's ROE is +0.39%, compared to MOH's ROE of -0.00%. Regarding short-term risk, OSCR is more volatile compared to MOH. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check MOH's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
OSCR vs CLOV Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, CLOV has a market cap of 2.3B. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while CLOV trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas CLOV's P/E ratio is 105.77. In terms of profitability, OSCR's ROE is +0.39%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, OSCR is more volatile compared to CLOV. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check CLOV's competition here
Progyny, Inc. (NASDAQ: PGNY)
OSCR vs PGNY Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, PGNY has a market cap of 2B. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while PGNY trades at $25.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas PGNY's P/E ratio is 26.77. In terms of profitability, OSCR's ROE is +0.39%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, OSCR is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check PGNY's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
OSCR vs ALHC Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, ALHC has a market cap of 1.6B. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while ALHC trades at $7.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas ALHC's P/E ratio is 40.37. In terms of profitability, OSCR's ROE is +0.39%, compared to ALHC's ROE of +0.20%. Regarding short-term risk, OSCR is more volatile compared to ALHC. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check ALHC's competition here
Bright Health Group, Inc. (NYSE: BHG)
OSCR vs BHG Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas BHG's P/E ratio is -0.12. In terms of profitability, OSCR's ROE is +0.39%, compared to BHG's ROE of +0.04%. Regarding short-term risk, OSCR is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for OSCR.Check BHG's competition here
Universal American Corporation (NYSE: UAM)
OSCR vs UAM Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, UAM has a market cap of 0. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas UAM's P/E ratio is 1.01. In terms of profitability, OSCR's ROE is +0.39%, compared to UAM's ROE of +0.17%. Regarding short-term risk, OSCR is more volatile compared to UAM. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check UAM's competition here
Triple-S Management Corporation (NYSE: GTS)
OSCR vs GTS Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, GTS has a market cap of 0. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas GTS's P/E ratio is 10.41. In terms of profitability, OSCR's ROE is +0.39%, compared to GTS's ROE of +0.07%. Regarding short-term risk, OSCR is more volatile compared to GTS. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check GTS's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
OSCR vs MGLN Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas MGLN's P/E ratio is 8.49. In terms of profitability, OSCR's ROE is +0.39%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, OSCR is more volatile compared to MGLN. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check MGLN's competition here
Aetna Inc. (NYSE: AET)
OSCR vs AET Comparison September 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.5B. In comparison, AET has a market cap of 0. Regarding current trading prices, OSCR is priced at $28.87 on the NYSE, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 20.61, whereas AET's P/E ratio is 9.57. In terms of profitability, OSCR's ROE is +0.39%, compared to AET's ROE of +0.11%. Regarding short-term risk, OSCR is more volatile compared to AET. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check AET's competition here